SEC Filings

10-12G/A
AMSURG CORP filed this Form 10-12G/A on 11/03/1997
Entire Document
 
<PAGE>   3
 
[AMSURG LETTERHEAD]
 
    
                                                                November 3, 1997
    
 
Dear American Healthcorp, Inc. Stockholder:
 
   
     Upon the distribution by American Healthcorp, Inc. ("AHC") of the shares of
AmSurg Common Stock owned by AHC (the "Distribution"), each of you will become
holders of AmSurg Corp. ("AmSurg") Class A common stock, no par value, and Class
B common stock, no par value. As an AHC stockholder you have indirectly owned an
interest in AmSurg because it has operated as a majority-owned subsidiary of AHC
since 1992. As a result of the Distribution, AmSurg will be an independent
public company with the ability to develop, finance and manage its business
separately from AHC. We appreciate your past support of AmSurg and would like to
welcome you as a direct stockholder in AmSurg at this exciting moment in the
company's history. We expect to continue our business as a leader in the
development, acquisition and operation of practice-based ambulatory surgery
centers. We believe the Distribution will position us to maximize our growth
potential.
    
 
     AmSurg was formed in April 1992 for the purpose of developing, acquiring
and operating practice-based ambulatory surgery centers, in partnerships with
physician practice groups, throughout the United States. Each of the surgery
centers provides a narrow range of high volume, lower-risk surgical procedures,
generally in a single specialty, and has been designed with a cost structure
that enables AmSurg to charge fees which management believes are generally less
than those charged by hospitals and freestanding outpatient surgery centers for
similar services performed on an outpatient basis. While the majority of
AmSurg's existing ambulatory surgery centers specialize in gastroenterology,
AmSurg's growth strategy focuses on the development and acquisition of
practice-based ambulatory surgery centers and the development of start-up
specialty physician networks in five specialties: gastroenterology,
ophthalmology, orthopaedic surgery, urology and otolaryngology.
 
   
     We are excited about operating AmSurg as an independent publicly traded
company and the opportunities for future development and growth of our business.
We expect these opportunities to translate into greater value to you and all
AmSurg stockholders.
    
 
                                          Sincerely,
 
                                          /s/ KEN P. MCDONALD
                                          -----------------------
                                          Ken P. McDonald
                                          President